4 ms·
The reverse actually. Whilst Oxford had the (generic) basis of the vaccine ready to go, prior to the COVID outbreak, it was the removal of all bureaucracy in t
by DrBazza 6y ago
The reverse actually.
Whilst Oxford had the (generic) basis of the vaccine ready to go, prior to the COVID outbreak, it was the removal of all bureaucracy in this, and other, vaccine trials, that has allowed them to go from r&d to approved in 10 months or so.
Which is apparently what researchers will tell you is the 'real' time it takes to develop a vaccine. No time writing proposals and rewriting them when they get rejected, no awaiting someone to approve the proposal, no applications and waiting for grant money, no time spent waiting for volunteers for clinical trial groups, and so on.
Regarding the dosage, more information here: https://www.bbc.co.uk/news/health-55308216 https://www.bbc.co.uk/news/health-55308216
(edit) and the time to develop here: https://www.bbc.co.uk/news/health-55041371 https://www.bbc.co.uk/news/health-55041371
- kenhwang 6y agoThe biggest speedup factor was how easy it was to get people sick. A certain number of people had to get sick within the trial groups before results could be conclusive. With how widespread COVID is and how many people caught it, they hit that requirement significantly faster than they normally would.
- andylynch 6y agoYes. Listened to one of the researchers talking about this. They said just that, this time difference here is almost all down to not waiting for funding or going through the usual grant process.